[1]
van Kraaij, T. et al. 2020. Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome. European Journal of Case Reports in Internal Medicine. 7, 5 (Apr. 2020). DOI:https://doi.org/10.12890/2020_001675.